Tag Archives: safety

In Brief: Increased Use of Cannabis During Pregnancy, But Little Data on Reproductive Safety

Despite decreasing rates of alcohol and tobacco use during pregnancy, the use of cannabis use during pregnancy is on the rise.  According to data collected from the National Survey on Drug Use and Health, the use of cannabis in pregnant women aged 18 to 44 years rose from 2.37% in 2002 to 3.85% in 2014… Read More »

Health Tip: Helmet Safety

News Consumer News Health Tip: Helmet Safety — A helmet can prevent someone from a serious head injury, says the New York State Department of Health. Some states even require people, especially children, to wear helmets while biking or skateboarding. The Department of Health encourages parents to: Select a helmet that meets Consumer Product Safety… Read More »

FDA draft guidance seeks better safety data for pregnant women

The Food and Drug Administration is proposing recommendations on how to better design studies to assess pregnancy outcomes in women exposed to FDA-regulated drugs and biological products. The new guidance includes sections on obtaining information from databases and electronic health records systems. According to the agency, its recommendations replace 2002 guidance issued to industry—which has… Read More »

Why analytics can offer a helping hand at safety net hospitals

Congress’ recent directive to Medicare to ease the burden of hospital readmission penalties on safety net hospitals that serve low-income patients was definitely a step in the right direction. After all, once patients with high social needs are discharged, there is much that’s outside the hospital’s control. It isn’t fair to penalize providers when they… Read More »

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »